IE

Kevin Duffy

This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Duffy. Retrieved from https://idiyas.com/inventor/kevin-duffy-xprrp6o8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Loading Chart...

Title: Kevin Duffy - Innovator in Fatty Liver Disorder Treatments

Introduction

Kevin Duffy is an accomplished inventor based in Ireland. He has made significant contributions to the field of medical treatments, particularly focusing on fatty liver disorders. His innovative approach aims to address critical health issues affecting many individuals worldwide.

Latest Patents

Kevin Duffy holds a patent titled "Compositions Comprising 15-Hepe and Use Thereof for Treating a Fatty Liver Disorder." This invention relates to compositions, formulations, and methods for treating fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The administration of 15-OHEPA is central to this treatment approach.

Career Highlights

Kevin Duffy has dedicated his career to advancing medical science through innovative solutions. He is currently associated with Dignity Sciences Limited, where he continues to develop and refine his ideas. His work is characterized by a commitment to improving patient outcomes and enhancing the quality of life for those affected by liver disorders.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Kevin Duffy's contributions to the treatment of fatty liver disorders highlight his innovative spirit and dedication to medical advancements. His work has the potential to make a significant impact on public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…